A research team from Massachusetts Institute of Technology (MIT) has developed a portable, non-invasive monitor that can detect a reduction in white blood cells among chemotherapy patients in one minute without drawing blood.
The research, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) and led by Carlos Castro-Gonzalez, was driven by the data that chemotherapy causes a sharp fall in white blood cells and nearly 17% of the time it causes infectious disease in the patient.
